Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.95 | 3.77 |
PEG Ratio (TTM) | -2.77 | -2.86 |
P/S Ratio (TTM) | 0.23 | 1.11 |
P/B Ratio (TTM) | 1.75 | 2.77 |
P/FCF Ratio (TTM) | -0.77 | 11.54 |
Price to 5YR AVG Earnings Ratio | -37.41 | 20.09 |
Price to 5YR AVG FCF Ratio | 588.53 | 9.28 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -44.65% | 3.33% |
ROE (TTM) | -51.35% | 15.64% |
Net Profit Margin (TTM) | -77.23% | 3.21% |
ROIC 5YR AVG | -5.33% | 14.60% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.19% | 182.43% | -90.67% |
Revenue | -0.26% | 14.74% | 4.71% |
Net Income | 5.69% | 179.63% | -93.49% |
Cash Flow | -1,354.08% | 853.56% | 338.55% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.47 | 3.26 |
Quick Ratio (TTM) | 1.26 | 2.56 |
D/E Ratio (TTM) | 0.09 | 1.64 |
Interest Coverage (TTM) | 544.83 | 26.25 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | N/A | 2.35 |
LTL to 5YR AVG FCF | 217.12 | 4.92 |
Shares Outstanding Growth 5YR AVG | 8.03% | -4.03% |